| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| PISKEL KYLE | Chief Financial Officer | C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVENUE EAST, SEATTLE | /s/ Kyle Piskel | 06 Mar 2026 | 0001780662 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADPT | Common Stock | Award | +61,875 | +29% | $0.000000* | 278,512 | 04 Mar 2026 | Direct |